Clinical Trial Update: 18F-FDG PET/CT-based Prognostic Model for Predicting Outcome in Patients With Diffuse Large B-cell Lymphoma [NA]

View source ↗

Summary

An update on a study evaluating an 18F-FDG PET/CT-based prognostic model to predict outcomes in patients with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Lymphoma, Large B-Cell, Diffuse | NA | Status: UNKNOWN